Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/1999
03/25/1999CA2296045A1 Persephin and related growth factors
03/25/1999CA2244978A1 Novel alcohol dehydrogenase
03/25/1999CA2244971A1 Mure
03/25/1999CA2244967A1 Murf
03/25/1999CA2244954A1 Murf
03/24/1999EP0903409A2 Aminopeptidase (AmpS)
03/24/1999EP0903406A1 Modulation of gene expression through interference with RNA secondary structure
03/24/1999EP0902836A1 Asymmetric hammerhead ribozymes
03/24/1999EP0902835A1 Purification of pharmaceutical-grade plasmid dna
03/24/1999EP0902791A1 Extracellular/epidermal growth factor hcaba58x
03/24/1999EP0902780A1 Quaternary cytofectins
03/24/1999EP0902682A2 Cationic virosomes as transfer system for genetic material
03/24/1999CN1211989A Composition and method for delivery of nucleic acids
03/24/1999CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants
03/24/1999CN1211923A Ligands to enhance cellular uptake of biomolecules
03/23/1999US5886166 Viricides; htlv; a trna primer for reverse transcription of a murine leukemia virus retroviral transfer vector having sequences in the primer binding site replaced to prevent strong base pairing with naturally occuring trna
03/23/1999US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5885971 Gene therapy by secretory gland expression
03/23/1999US5885970 Antisense oligonucleotides against human protein kinase C
03/23/1999US5885836 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
03/23/1999US5885833 Nucleic acid constructs for the cell cycle-regulated expression of genes and therapeutic methods utilizing such constructs
03/23/1999US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting
03/23/1999US5885806 Methods to prepare conditionally replicating viral vectors
03/23/1999US5885805 gbpA
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885777 A nucleotide sequence encoding an active phosphatidylinositol-3-kinase consisting of specific amino acid sequences or a nucleotide sequence which hybridizes with above nucleotide sequences after washing in low salt buffer
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/22/1999CA2244239A1 Novel era
03/22/1999CA2244237A1 A human lig-1 homolog (hlig-1)
03/18/1999WO1999013092A1 Enhancement of mucosal antibody responses by interleukin-6
03/18/1999WO1999013086A1 PROTEIN WITH THE AMINO ACID SEQUENCE OF Δ7 STEROL REDUCTASE, ISOLATED cDNA MOLECULE CODING FOR SAID PROTEIN, RECOMBINANT DNA VECTOR AND BIOLOGICALLY ACTIVE COMPOSITIONS CONTAINING SAID PROTEIN OR SAID cDNA MOLECULE
03/18/1999WO1999013078A1 Cysteine rich receptors-train
03/18/1999WO1999013073A2 Viral vector system capable of expressing an apoptosis-associated gene
03/18/1999WO1999013071A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999WO1999013067A2 Hypoxia inducible promoter
03/18/1999WO1999013064A2 Viral infection of cells using viral vectors
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999013053A1 Genetically modified tumor-targeted bacteria with reduced virulence
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012963A2 Cysteine rich receptors: trail
03/18/1999WO1999012945A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use
03/18/1999WO1999012576A2 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
03/18/1999WO1999012575A1 Method of in vivo transformation utilizing lipid vehicles
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012557A1 Novel prokaryotic polynucleotides, polypeptides and their uses
03/18/1999WO1999012414A1 Transplacental delivery of oligonucleotides
03/18/1999WO1999000516A3 Neuronal stem cell gene
03/18/1999WO1998058956A3 Methods for inducing an immune response involving prime-boost protocols
03/18/1999WO1998058953A3 Surface exposed proteins from chlamydia pneumoniae
03/18/1999WO1998058629A3 Preparation of pharmaceutical compositions
03/18/1999WO1998057983A3 Mammalian neuro-growth factor like protein
03/18/1999WO1998053063A3 Mammalian cell transduction for use in gene therapy
03/18/1999WO1998052614A3 Composition and method for enhancing transport across biological membranes
03/18/1999WO1998044103A3 Protein for inhibiting apoptosis
03/18/1999DE19740092A1 New liposome comprises lipid envelope based on natural or synthetic skin
03/18/1999DE19739940A1 Protein mit Aminosäuresequenz der DELTA7-Sterolreduktase, isoliertes cDNA-Molekül, das für das Protein kodiert, rekombinanter DNA-Vektor und biologisch aktive Zusammensetzungen, die das Protein oder das cDNA-Molekül enthalten Protein having amino acid sequence of Delta7-Sterolreduktase, isolated cDNA molecule which encodes the protein A recombinant DNA vector, and biologically active compositions containing the protein or cDNA molecule
03/18/1999CA2305575A1 Hydrophobic glycosylamine derivatives, compositions, and methods for use
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303616A1 Transplacental delivery of oligonucleotides
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303402A1 Hypoxia inducible promoter
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302148A1 Human papilloma virus inhibition by anti-sense oligonucleotides
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2301173A1 Cysteine rich receptors-train
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999CA2244325A1 Novel amps
03/18/1999CA2244323A1 Novel gapdh
03/17/1999EP0902090A1 Compound capable of introducing at least one molecule into a cell.
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0844871A4 A process for preparing microparticles through phase inversion phenomena
03/17/1999CN1211279A Composition and methods for the treatment and diagnosis of breast cancer
03/17/1999CN1211255A Ob receptor and method of diagnosing and treating weight
03/17/1999CA2244330A1 Novel histidine kinase
03/16/1999US5883239 aroA
03/16/1999US5883228 Functionally active regions of signal transducer and activator of transcription
03/16/1999US5883082 Compositions and methods for preventing and treating allograft rejection
03/16/1999US5882927 Oligonucleotide inhibition of protein kinase C
03/16/1999US5882925 Cdna contained in plasmids, amino acid sequences and cultures
03/16/1999US5882914 Nucleic acids encoding the hypoxia inducible factor-1
03/16/1999US5882912 Retrovirus isolated from humans
03/16/1999US5882897 yitJ
03/16/1999US5882892 Polypeptides and dna(rna) encoding and screening for bactericides
03/16/1999US5882891 Polynucleotide segments
03/16/1999US5882889 Response regulator in a two component signal transduction system
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882877 Cystic fibrosis treatment; genetic engineering
03/16/1999US5882876 Amino acid sequences in proteins and markers of cancer cells
03/16/1999US5882871 Saliva binding protein
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 870